Torecan

Active Ingredient(s): Thiethylperazine
FDA Approved: * July 18, 1961
Pharm Company: * NOVARTIS
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Torecan Overview

Thiethylperazine (Torecan) is an antiemetic of the phenothiazine class. Though it was never licensed or used as an antipsychotic, it may have such effects. Thiethylperazine activates the transport protein ABCC1 that clears beta-amyloid from brains of mice.[1] References ^ Science Daily (September 1, 2011). "Alzheimer Disease: Transport Protein ABCC1 Plays Key Role in Clearing Beta-Amyloid from Brains of Mice". Retrieved September 1, 2011..mw-parser-output cite.citation{f...

Read more Torecan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Thiethylperazine

Recent Torecan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Thiethylperazine
  • Injection: 10mg/2ml, 5mg/ml
  • Suppository: 10mg
  • Tablet: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Thiethylperazine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA